Active, Not Recruiting
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
NCT03529422
- Conditions
- Digestive Organs--Diseases, Head and Neck Neoplasms, Laryngeal Diseases, +11 more
- Locations
-
- University Of Alabama At Birmingham Birmingham, Alabama, United States
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
- Medical University of South Carolina - Hollings Cancer Center Charleston, South Carolina, United States